Continuous manufacturing said to enable faster clinical and commercial pathways

By Jane Byrne contact

- Last updated on GMT

© GettyImages/gorodenkoff
© GettyImages/gorodenkoff

Related tags: continuous processes, batch, Software

When it comes to continuous manufacturing, software challenges are greater than the hardware challenges faced in setting up a new manufacturing line, because at this time, due to a lack of standardization, debugging and validation can be significant components of the overall timeline, says an industry insider.

Doug Hausner, senior manager, continuous manufacturing business development, Pharma Services, Thermo Fisher Scientific, said such hurdles, among others, makes partnering with established vendors or CDMOs particularly important as the business case and associated timelines for the continuous manufacturing platform often will not work for a single product, and the decision to adopt the technology should be made early on or more broadly.  

Continuous manufacturing (CM), whether it be for small or large molecule, provides a number of advantages to the drug developer/manufacturer, he commented.  

“The benefits of quality, speed of development, and cost of goods sold are shared between a contract development and manufacturing organization (CDMO) and their customer. 

“Once adopted, CM is a faster pathway from development to clinical and onto commercial since the traditional aspects of scale-up are removed.  

“Additionally, the nature of continuous processes enables real-time quality monitoring in almost all cases, which often can be extended to real-time release. These factors combined provide for an agile approach to new product introduction,” ​he told this publication. 

Slow adoption

Still, noted Hausner, given that CM produces the same product as the traditional batch process, adoption can be slow, and users have the option of waiting until the process technology is fully commercially ready.

“Much of the commercial readiness for this type of technology is related to the interconnectivity of the units making up the manufacturing train. 

“There is a need for control software that oversees the entire process train and communicates between the comprising components utilizing process information, which is being collected and processed in real-time.”

Related news

Show more

Related products

show more

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Related suppliers

Follow us

Products

View more

Webinars